Rankings
▼
Calendar
ALDX Q1 2025 Earnings — Aldeyra Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ALDX
Aldeyra Therapeutics, Inc.
$318M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$10M
Net Income
-$10M
EPS (Diluted)
$-0.17
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$12M
Free Cash Flow
-$12M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$93M
Total Liabilities
$30M
Stockholders' Equity
$64M
Cash & Equivalents
$50M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$10M
-$9M
-11.0%
Net Income
-$10M
-$8M
-22.9%
← FY 2025
All Quarters
Q2 2025 →